# reload+after+2024-01-19 21:43:36.306717
address1§11085 Torreyana Road
city§San Diego
state§CA
zip§92121
country§United States
phone§858 558 0708
fax§858 558 0701
website§https://www.bioatla.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and head and neck cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.
fullTimeEmployees§66
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Jay M. Short Ph.D.', 'age': 65, 'title': 'Co-Founder, CEO & Chairman', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 1057809, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Richard A. Waldron', 'age': 69, 'title': 'Senior VP & CFO', 'yearBorn': 1954, 'fiscalYear': 2022, 'totalPay': 617616, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Eric L. Sievers M.D.', 'age': 59, 'title': 'Chief Medical Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 608178, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christian J. Vasquez', 'age': 47, 'title': 'Senior VP of Finance, Corporate Controller & Secretary', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 408745, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Lisa M. Pelton', 'title': 'Accounting Manager', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Susie  Melody', 'title': 'Senior Vice President of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Cathy  Chang Ph.D.', 'title': 'Senior Vice President of Research & Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Gerhard  Frey Ph.D.', 'title': 'Senior Vice President of Technology Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Monica  Sullivan', 'title': 'Senior Vice President of Intellectual Property & Contracts', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sheri  Lydick', 'title': 'Chief Commercial Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§8
compensationRisk§6
shareHolderRightsRisk§8
overallRisk§7
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.834
currency§USD
dateShortInterest§1702598400
forwardEps§-2.55
exchange§NGM
quoteType§EQUITY
shortName§BioAtla, Inc.
longName§BioAtla, Inc.
firstTradeDateEpochUtc§1608129000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§35fd9bcd-d23c-3ada-beff-01d8b746a34b
gmtOffSetMilliseconds§-18000000
targetHighPrice§14.0
targetLowPrice§10.0
targetMeanPrice§12.25
targetMedianPrice§12.5
recommendationMean§1.6
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§3.968
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
